PP_1170x120_10-25-21

Bromfenac Ophthalmic Solution

Aurobindo gets FDA approval for Bromfenac Ophthalmic Solution

Aurobindo gets FDA approval for Bromfenac Ophthalmic Solution

EAST WINDSOR, N.J. – Aurobindo Pharma has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Bromfenac Ophthalmic Solution 0.09%. Aurobindo Pharma’s Bromfenac Ophthalmic Solution, are an AT-rated generic equivalent to the reference listed drug (RLD), Bromday Ophthalmic Solution, of Bausch & Lomb. Bromfenac Ophthalmic Solution are indicated for